MannKind Corporation (MNKD), focused on discovering, developing and commercializing treatments
for diabetes and cancer, announced today that it will present at The 24th Annual Piper Jaffray Healthcare Conference on Tuesday, November 27, 2012 at 1:00 PM (EST) at The New York Palace in New York.
I'm not trying to push any rumor going into this next conference but I just read a week or so ago that Piper Jaffray advised China Kanghui on an $816 million sale to Medtronic, Inc. The Chineese company was a decent sized provider of orthopedic devices in China. I had traded the stock several times in the past. And we all know about Medtronic and MiniMed Inc.
I would not be surprised to see Al deal with Medtronic again.
Al is involved with all the right players in this one.